Literature DB >> 10536682

Aldosterone and the heart: towards a physiological function?

C Delcayre1, J S Silvestre.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10536682     DOI： 10.1016/s0008-6363(99)00088-7

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  10 in total

1.  Effects of aldosterone on transient outward K+ current density in rat ventricular myocytes.

Authors:  J P Bénitah; E Perrier; A M Gómez; G Vassort
Journal:  J Physiol       Date:  2001-11-15       Impact factor: 5.182

Review 2.  Clinical implications of physiological changes in the aging heart.

Authors:  K G Pugh; J Y Wei
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

3.  Altered potassium balance and aldosterone secretion in a mouse model of human congenital long QT syndrome.

Authors:  I Arrighi; M Bloch-Faure; F Grahammer; M Bleich; R Warth; R Mengual; M D Drici; J Barhanin; P Meneton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 4.  Diastolic heart failure in the elderly and the potential role of aldosterone antagonists.

Authors:  Ashwani Kumar; Gary Meyerrose; Vineeta Sood; Chanwit Roongsritong
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

5.  Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?

Authors:  Wenxia Chai; Ingrid M Garrelds; Udayasankar Arulmani; Regien G Schoemaker; Jos M J Lamers; A H Jan Danser
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

6.  A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule.

Authors:  Jérôme Fagart; Alexander Hillisch; Jessica Huyet; Lars Bärfacker; Michel Fay; Ulrich Pleiss; Elisabeth Pook; Stefan Schäfer; Marie-Edith Rafestin-Oblin; Peter Kolkhof
Journal:  J Biol Chem       Date:  2010-07-22       Impact factor: 5.157

7.  Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes.

Authors:  Ahmed T Beggah; Brigitte Escoubet; Stefania Puttini; Stephane Cailmail; Vanessa Delage; Antoine Ouvrard-Pascaud; Brigitte Bocchi; Michel Peuchmaur; Claude Delcayre; Nicolette Farman; Frederic Jaisser
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

Review 8.  Effect of MR blockade on collagen formation and cardiovascular disease with a specific emphasis on heart failure.

Authors:  Faiez Zannad; Anca Radauceanu
Journal:  Heart Fail Rev       Date:  2005-01       Impact factor: 4.214

9.  Aldosterone-induced cardiac damage in primary aldosteronism depends on its subtypes.

Authors:  Satoshi Higuchi; Hideki Ota; Yuta Tezuka; Kazumasa Seiji; Hidenobu Takagi; Jongmin Lee; Yi-Wei Lee; Kei Omata; Yoshikiyo Ono; Ryo Morimoto; Masataka Kudo; Fumitoshi Satoh; Kei Takase
Journal:  Endocr Connect       Date:  2021-01       Impact factor: 3.335

10.  CYP11B2 T-344C gene polymorphism and atrial fibrillation: a meta-analysis of 2,758 subjects.

Authors:  Yan-yan Li; Chuan-wei Zhou; Jian Xu; Yun Qian; Bei Wang
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.